Candidiasis can be present as a cutaneous, mucosal or deep-seated organ infection, which
is caused by more than 20 types of Candida sp., with C. albicans being the most common …

Candida glabrata has thoroughly adapted to successfully colonize human mucosal
membranes and survive in vivo pressures. prior to and during antifungal treatment. Out of all …

Understanding how microbial pathogens adapt to treatments, humans and clinical
environments is key to infer mechanisms of virulence, transmission and drug resistance …

Candida albicans and Candida glabrata are the two most prevalent etiologic agents of
candidiasis worldwide. Although both are recognized as pathogenic, their choice of …

Candidiasis is a highly pervasive infection posing major health risks, especially for
immunocompromised populations. Pathogenic Candida species have evolved intrinsic and …

Fungal pathogens pose an increasingly worrying threat to human health, food security and
ecosystem diversity. To tackle fungal infections and improve current diagnostic and …

Candida glabrata is an opportunistic fungal pathogen that currently ranks as the second
most common cause of candidiasis. Although the mechanisms underlying virulence and …

Infections by the pathogenic yeasts Candida albicans and Candida glabrata are among the
most common fungal diseases. The success of these species as human pathogens is …

The emergence of drug resistance significantly hampers the treatment of human infections,
including those caused by fungal pathogens such as Candida species. Candida glabrata …

Objectives This study aimed to identify the resistance mechanisms to micafungin and
fluconazole in a clinical isolate of Candida glabrata. Methods The isolate was whole …